CCND1 and hepatocellular carcinoma: DOX-AuNPs group showed a significant decrease in hepatic Cyclin D1 level by 47.12% (p < 0.001) as compared to the HCC group, and by 25.28% (p < 0.001) as compared to the DOX group.